Publications
Detailed Information
Discovery of Novel Dual Adenosine A(2A) and A(1) Receptor Antagonists with 1H-Pyrazolo[3,4-d]pyrimidin-6-amine Core Scaffold as Anti-Parkinson's Disease Agents
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jung, Juyoung | - |
dc.contributor.author | Lee, Yoonsuk | - |
dc.contributor.author | Moon, An-Na | - |
dc.contributor.author | Ann, Jihyae | - |
dc.contributor.author | Jeong, Jin Ju | - |
dc.contributor.author | Do, Nayeon | - |
dc.contributor.author | Lee, Jeewoo | - |
dc.date.accessioned | 2022-10-11T00:49:35Z | - |
dc.date.available | 2022-10-11T00:49:35Z | - |
dc.date.created | 2022-09-08 | - |
dc.date.issued | 2022-08 | - |
dc.identifier.citation | Pharmaceuticals, Vol.15 No.8, p. 922 | - |
dc.identifier.issn | 1424-8247 | - |
dc.identifier.uri | https://hdl.handle.net/10371/185692 | - |
dc.description.abstract | New compounds with 1H-pyrazolo [3,4-d]pyrimidin-6-amine core scaffolds were synthesized and characterized in vitro to determine their affinity for human A(2A) and A(1) receptors. Among the tested compounds, a few compounds displayed nanomolar binding affinities for both receptors. One particular compound, 11o, showed high binding activities (hA(2A) K-i = 13.3 nM; hA(1) K-i = 55 nM) and full antagonism (hA(2A) IC50 = 136 nM; hA(1) IC50 = 98.8 nM) toward both receptors. Further tests showed that 11o has low hepatic clearance and good pharmacokinetic properties in mice, along with high bioavailability and a high brain plasma ratio. In addition, 11o was associated with very low cardiovascular risk and mutagenic potential, and was well-tolerated in rats and dogs. When tested in an MPTP-induced mouse model of Parkinson's disease, 11o tended to improve behavior. Moreover, 11o dose-dependently reversed haloperidol-induced catalepsy in female rats, with graded ED50 of between 3 and 10 mg/kg. Taken together, these results suggest that this potent dual A(2A)/A(1) receptor antagonist, 11o, is a good candidate for the treatment of Parkinson's disease with an excellent metabolic and safety profile. | - |
dc.language | 영어 | - |
dc.publisher | Multidisciplinary Digital Publishing Institute (MDPI) | - |
dc.title | Discovery of Novel Dual Adenosine A(2A) and A(1) Receptor Antagonists with 1H-Pyrazolo[3,4-d]pyrimidin-6-amine Core Scaffold as Anti-Parkinson's Disease Agents | - |
dc.type | Article | - |
dc.identifier.doi | 10.3390/ph15080922 | - |
dc.citation.journaltitle | Pharmaceuticals | - |
dc.identifier.wosid | 000845705200001 | - |
dc.identifier.scopusid | 2-s2.0-85137376572 | - |
dc.citation.number | 8 | - |
dc.citation.startpage | 922 | - |
dc.citation.volume | 15 | - |
dc.description.isOpenAccess | N | - |
dc.contributor.affiliatedAuthor | Lee, Jeewoo | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.